Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Proteome Res ; 12(10): 4490-6, 2013 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-23984816

RESUMO

Ovarian cancer is the fifth leading cause of cancer-related mortalities for women in the United States and the most lethal gynecological cancer. Aberrant glycosylation has been linked to several human diseases, including ovarian cancer, and accurate measurement of changes in glycosylation may provide relevant diagnostic and prognostic information. In this work, we used microchip electrophoresis coupled with laser-induced fluorescence detection to determine quantitative differences among the N-glycan profiles of control individuals and late-stage recurrent ovarian cancer patients prior to and after an experimental drug treatment that combined docetaxel and imatinib mesylate. N-Glycans were enzymatically released from 5-µL aliquots of serum samples, labeled with the anionic fluorescent tag, 8-aminopyrene-1,3,6-trisulfonic acid, and analyzed on microfluidic devices. A 22-cm long separation channel, operated at 1250 V/cm, generated analysis times less than 100 s, separation efficiencies up to 8 × 10(5) plates (3.6 × 10(6) plates/m), and migration time reproducibilities better than 0.1% relative standard deviation after peak alignment. Principal component analysis (PCA) and analysis of variance (ANOVA) tests showed significant differences between the control and both pre- and post-treatment cancer samples and subtle differences between the pre- and post-treatment cancer samples. Area-under-the-curve (AUC) values from receiver operating characteristics (ROC) tests were used to evaluate the diagnostic merit of N-glycan peaks, and specific N-glycan peaks used in combination provided AUCs > 0.90 (highly accurate test) when the control and pretreatment cancer samples and control and post-treatment samples were compared.


Assuntos
Biomarcadores Tumorais/sangue , Recidiva Local de Neoplasia/sangue , Neoplasias Ovarianas/sangue , Polissacarídeos/sangue , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Área Sob a Curva , Benzamidas/administração & dosagem , Estudos de Casos e Controles , Docetaxel , Eletroforese em Microchip , Feminino , Glicoproteínas/sangue , Glicosilação , Humanos , Mesilato de Imatinib , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/tratamento farmacológico , Neoplasias Ovarianas/tratamento farmacológico , Piperazinas/administração & dosagem , Análise de Componente Principal , Processamento de Proteína Pós-Traducional , Pirimidinas/administração & dosagem , Curva ROC , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Taxoides/administração & dosagem
2.
Glycobiology ; 22(12): 1684-708, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22781126

RESUMO

Glycosylation is a key post-translational protein modification which appears important in malignant transformation and tumor metastasis. Abnormal glycosylation of different proteins can often be measured in the blood serum. In this study, we extend our serum-based structural investigations to samples provided by patients diagnosed with lung cancer, paying particular attention to the effects of smoking on the serum glycomic traces. Following a battery of glycomic tests, we find that several fucosylated tetra-antennary structures with varying degrees of sialylation are increased in their abundances in control samples provided by the former smokers, with further elevations in the lung cancer patients who were former smokers. Further detailed investigations demonstrated that the level of outer-arm fucosylation was elevated in the control samples of the former smokers and again in the lung cancer samples provided by the former smokers. This trend was particularly noticeable for the tri- and tetra-antennary structures. Different ratios of sialylation linkages were also observed that could be correlated with the different states of health and smoking status. Decreases in the abundance levels of isomers with two and three α2,3-linked sialic acids and an increased abundance of an isomer with two α2,6-linked sialic acids were noted for a fucosylated tri-sialylated tri-antennary glycan. These results demonstrate the long-term effects of smoking on glycomic profiles and that this factor needs to be considered in these and other serum-based analyses.


Assuntos
Proteínas Sanguíneas/metabolismo , Neoplasias Pulmonares/metabolismo , Carcinoma de Pequenas Células do Pulmão/metabolismo , Fumar/metabolismo , Estudos de Casos e Controles , Fucose/metabolismo , Glicômica , Glicosilação , Humanos , Neoplasias Pulmonares/sangue , Polissacarídeos/metabolismo , Proteoglicanas/metabolismo , Ácidos Siálicos/metabolismo , Carcinoma de Pequenas Células do Pulmão/sangue , Fumar/sangue
3.
J Proteome Res ; 11(4): 2282-300, 2012 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-22304416

RESUMO

Glycosylated proteins play important roles in a broad spectrum of biochemical and biological processes, and prior reports have suggested that changes in protein glycosylation occur during cancer initiation and progression. Ovarian cancer (OC) is a fatal malignancy, most commonly diagnosed after the development of metastases. Therefore, early detection of OC is key to improving survival. To this end, specific changes of the serum glycome have been proposed as possible biomarkers for different types of cancers. In this study, we extend this concept to OC. To characterize differences in total N-glycan levels, serum samples provided by 20 healthy control women were compared to those acquired from patients diagnosed with late-stage recurrent OC who were enrolled in an experimental treatment trial prior to receiving therapy (N=19) and one month later, prior to the second treatment cycle (N=11). Additionally, analyses of the N-glycans associated with IgG and characterization of the relative abundance levels of core vs outer-arm fucosylation were also performed. The N-linked glycomic profiles revealed increased abundances of tri- and tetra-branched structures with varying degrees of sialylation and fucosylation and an apparent decrease in the levels of "bisecting" glycans in OC samples compared to controls. Increased levels of a-galactosylation structures were observed on N-linked glycans derived from IgG, which were independent of the presence of fucose residues. Elevated levels of outer-arm fucosylation were also identified in the OC samples. These results allowed the control samples to be distinguished from the baseline ovarian cancer patients prior to receiving the experimental treatment. In some cases, the pre-treatment samples could be distinguished from the post-experimental treatment samples, as many of those patients showed a further progression of the disease.


Assuntos
Biomarcadores Tumorais/sangue , Neoplasias Ovarianas/sangue , Polissacarídeos/sangue , Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Benzamidas , Biomarcadores Tumorais/biossíntese , Biomarcadores Tumorais/química , Sequência de Carboidratos , Estudos de Casos e Controles , Docetaxel , Feminino , Fucose/análise , Glicômica/métodos , Humanos , Mesilato de Imatinib , Imunoglobulina G/sangue , Imunoglobulina G/química , Metilação , Neoplasias Ovarianas/tratamento farmacológico , Piperazinas/administração & dosagem , Polissacarídeos/biossíntese , Polissacarídeos/química , Pirimidinas/administração & dosagem , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Taxoides/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...